Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01701466 | Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis | terminated | Phase 2 | 14 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01750164 | Patient Derived Breast Cancer Xenografts | terminated | — | 1 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00351858 | Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer(IV REXBC 02) | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | May 1, 2015 | clinicaltrials |
| NCT01569321 | Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study | terminated | N/A | 10 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01071564 | RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery | terminated | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01368263 | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | terminated | Phase 2 | 8 | Washington University School of MedicineOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT00450879 | Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery | terminated | Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Mar 25, 2015 | clinicaltrials |
| NCT01019512 | Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer | terminated | N/A | 60 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT02008994 | Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer | terminated | Phase 2 | 5 | Sanford HealthOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT00132002 | Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer | terminated | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2015 | clinicaltrials |
| NCT01239251 | GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy | terminated | — | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT02024074 | Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients | terminated | Phase 1 | 1 | Emory UniversityOTHER | 1 | Feb 6, 2015 | clinicaltrials |
| NCT00539968 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | terminated | Phase 1 / Phase 2 | 5 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 5, 2015 | clinicaltrials |
| NCT01166581 | Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates | terminated | — | 300 | Summa Health SystemOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT00903006 | Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT00525161 | Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer | terminated | Phase 2 | 11 | Suleiman MassarwehOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01194908 | Re-expression of ER in Triple Negative Breast Cancers | terminated | Phase 1 / Phase 2 | 5 | Emory UniversityOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | terminated | Phase 1 | 54 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01290718 | A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. | terminated | Phase 2 | 4 | Hoffmann-La RocheINDUSTRY | 1 | Dec 17, 2014 | clinicaltrials |
| NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | terminated | Phase 3 | — | UNICANCEROTHER | 1 | Dec 16, 2014 | clinicaltrials |
| NCT01207102 | Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 10 | Duke UniversityOTHER | 2 | Dec 15, 2014 | clinicaltrials |
| NCT01238029 | Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer(CELAVIE) | terminated | Phase 1 | 12 | Sponsor GmbHOTHER | 1 | Nov 21, 2014 | clinicaltrials |
| NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | terminated | Phase 2 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT00082095 | To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older | terminated | Phase 3 | 62 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 1 | Oct 9, 2014 | clinicaltrials |
| NCT01928615 | A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer(LISAH) | terminated | Phase 2 | 2 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01300871 | Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer | terminated | — | 100 | University Health Network, TorontoOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT01272141 | A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Emory UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00570908 | Brain Mets - Capecitabine Plus Sunitinib and WBRT | terminated | Phase 2 | 12 | Baylor Breast Care CenterOTHER | 1 | Sep 18, 2014 | clinicaltrials |
| NCT01333137 | A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin | terminated | Phase 1 | 11 | Piramal Enterprises LimitedINDUSTRY | 1 | Sep 4, 2014 | clinicaltrials |
| NCT00691912 | Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin(MyoPac) | terminated | Phase 2 | 26 | Claudia Lorenz-SchlüterOTHER | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00524459 | Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 6 | Roswell Park Cancer InstituteOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01430585 | Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer | terminated | Phase 2 | 14 | PfizerINDUSTRY | 4 | Aug 12, 2014 | clinicaltrials |
| NCT00576901 | A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. | terminated | Phase 2 | 23 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01363986 | A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 3 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01113905 | Role of Beta-Endorphin in Cancer Therapy Fatigue | terminated | — | 18 | Massachusetts General HospitalOTHER | 1 | Aug 7, 2014 | clinicaltrials |
| NCT01276054 | Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. | terminated | Phase 2 | 4 | University of Southern CaliforniaOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT00925548 | STRIDE - STimulating Immune Response In aDvanced brEast Cancer(STRIDE) | terminated | Phase 3 | 16 | EMD SeronoINDUSTRY | 12 | Jul 24, 2014 | clinicaltrials |
| NCT00930527 | Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors | terminated | Phase 2 | 10 | Columbia UniversityOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00744653 | Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects. | terminated | Phase 2 | 17 | Copenhagen University Hospital at HerlevOTHER | 1 | Jul 18, 2014 | clinicaltrials |
| NCT00165880 | An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine | terminated | Phase 2 | 62 | Eisai LimitedINDUSTRY | 5 | Jul 1, 2014 | clinicaltrials |
| NCT00128362 | Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer | terminated | Phase 2 | 478 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00555477 | Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure | terminated | Phase 2 | 69 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00079326 | Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer | terminated | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2014 | clinicaltrials |
| NCT00159458 | Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 7 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183963 | A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) | terminated | Phase 2 | 4 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01329640 | Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01) | terminated | Phase 2 | 9 | Instituto do Cancer do Estado de São PauloOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00674011 | Hypertension in Breast Cancer Patients Receiving Bevacizumab | terminated | — | 10 | Dana-Farber Cancer InstituteOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01355523 | The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients(MELODY) | terminated | Phase 2 / Phase 3 | 54 | Melissa Voigt HansenOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01300585 | MRI Evaluation of the Breast Areolar Margin and Paryenchyma(Breast MRI) | terminated | N/A | 68 | Piedmont HealthcareOTHER | 1 | May 5, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 25, 2015source: clinicaltrials